Aurobindo Pharma Sees 11.14% Surge in Open Interest to 67,032 Contracts

Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 67,032 contracts, reflecting a rise of 6,718 contracts or 11.14% from the previous open interest of 60,314. This uptick coincides with a trading volume of 27,938 contracts, indicating active participation in the market.
In terms of price performance, Aurobindo Pharma has outperformed its sector by 3.56%, reaching an intraday high of Rs 1,155.8, which marks a 4.83% increase for the day. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend in its price trajectory.

However, it is noteworthy that the delivery volume has decreased by 32.62% compared to the 5-day average, with a total of 4.63 lakh shares delivered on October 30. Despite this decline in delivery participation, the stock remains liquid, with a trading capacity of Rs 2.58 crore based on 2% of the 5-day average traded value.

In summary, Aurobindo Pharma's notable increase in open interest and solid price performance highlight its current market dynamics, while the decline in delivery volume presents a contrasting aspect of investor engagement.